Combined prophylactic and therapeutic immune responses against human papillomaviruses induced by a thioredoxin-based L2-E7 nanoparticle vaccine-Reference-Cited by-同舟云学术

Combined prophylactic and therapeutic immune responses against human papillomaviruses induced by a thioredoxin-based L2-E7 nanoparticle vaccine

Published:2020-09-04 Issue:9 Volume:16 Page:e1008827
ISSN:1553-7374
Container-title:PLOS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Zhao Xueer^ORCID,Yang Fan,Mariz Filipe,Osen Wolfram^ORCID,Bolchi Angelo,Ottonello Simone^ORCID,Müller Martin^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference58 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;F Bray;CA: a cancer journal for clinicians,2018

2. IARC [Internet]. Global Cancer Observatory (GLOBOCAN) Cancer Tomorrow 2018 Estimates. https://gco.iarc.fr/tomorrow/home.

3. Papillomaviruses in the causation of human cancers—a brief historical account;H zur Hausen;Virology,2009

4. Against which human papillomavirus types shall we vaccinate and screen? The international perspective;N Munoz;International journal of cancer,2004

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotherapy for human papillomavirus-associated cancers: breakthroughs and challenges;Trends in Pharmacological Sciences;2024-09

2. A safe and potentiated multi-type HPV L2-E7 nanoparticle vaccine with combined prophylactic and therapeutic activity;npj Vaccines;2024-06-26

3. The Chemokine CXCL14 as a Potential Immunotherapeutic Agent for Cancer Therapy;Viruses;2024-02-16

4. A broadly protective vaccine against cutaneous human papillomaviruses;npj Vaccines;2022-10-10

5. Combination therapy between prophylactic and therapeutic human papillomavirus (HPV) vaccines with special emphasis on implementation of nanotechnology;Microbial Pathogenesis;2022-10